Abstract:Introduction In 2020, nations hastened to contain an emerging COVID-19 pandemic by deploying diverse public health approaches, but conclusive appraisals of the efficacy of these approaches are elusive in most cases. One of the medicines deployed, ivermectin (IVM), a macrocyclic lactone having biochemical activity against SARS-CoV-2 through competitive binding to its spike protein, has yielded mixed results in randomized clinical trials (RCTs) for COVID-19 treatments. In Peru, an opportunity to track the efficacy of IVM with a close consideration of confounding factors was provided through data for excess deaths as correlated with IVM use in 2020, under semi-autonomous policies in its 25 states. Methods To evaluate possible IVM treatment effects, excess deaths as determined from Peruvian national health data were analyzed by state for ages ≥60 in Peru's 25 states. These data were compared with monthly summary data for excess deaths in Peru for the period 2020-2021 as published by the WHO in 2022. To identify potential confounding factors, Google mobility data, population densities, SARS-CoV-2 genetic variations, and seropositivity rates were also examined. Results Reductions in excess deaths over a period of 30 days after peak deaths averaged 74% in the 10 states with the most intensive IVM use. As determined across all 25 states, these reductions in excess deaths correlated closely with the extent of IVM use (p<0.002). During four months of IVM use in 2020, before a new president of Peru restricted its use, there was a 14-fold reduction in nationwide excess deaths and then a 13-fold increase in the two months following the restriction of IVM use. Notably, these trends in nationwide excess deaths align with WHO summary data for the same period in Peru. Conclusions The natural experiment that was put into motion with the authorization of IVM use for COVID-19 in Peru in May 2020, as analyzed using data on excess deaths by locality and by state from Peruvian national health sources, resulted in strong evidence for the drug's effectiveness. Several potential confounding factors, including effects of a social isolation mandate imposed in May 2020, variations in the genetic makeup of the SARS-CoV-2 virus, and differences in seropositivity rates and population densities across the 25 states, were considered but did not appear to have significantly influenced these outcomes.

Excess deaths hidden 100 days after the quarantine in Peru by COVID-19

COVID-19 Excess Deaths in Peru’s 25 States in 2020: Nationwide Trends, Confounding Factors, and Correlations With the Extent of Ivermectin Treatment by State

Geospatial analysis of cardiovascular mortality before and during the COVID-19 pandemic in Peru: analysis of the national death registry to support emergency management in Peru

Modelling death rates due to COVID-19: A Bayesian approach

Estimating mortality and disability in Peru before the COVID-19 pandemic: a systematic analysis from the Global Burden of the Disease Study 2019

A proposed analytical approach to estimate excess daily mortality rates in Ecuador

Impact of the COVID‐19 pandemic on the incidence of dengue fever in Peru

Significancia estadística del exceso de muertes en Chile durante pandemia COVID-19

A comprehensive analysis of cardiovascular mortality trends in Peru from 2017 to 2022: Insights from 183,386 deaths of the national death registry

Global Excess Mortality During COVID-19 Pandemic: A Systematic Review and Meta-Analysis

An assessment of excess mortality during the COVID-19 pandemic, a retrospective post-mortem surveillance in 12 districts - Zambia, 2020-2022

Using excess deaths and testing statistics to improve estimates of COVID-19 mortalities

The WHO estimates of excess mortality associated with the COVID-19 pandemic

Conventional and frugal methods of estimating COVID-19-related excess deaths and undercount factors

A U-shaped protection of altitude against mortality and infection of COVID-19 in Peru: an ecological study

Estimating excess mortality during the Covid-19 pandemic in Aotearoa New Zealand

Negative Cognitive and Psychological Correlates of Mandatory Quarantine During the Initial COVID-19 Outbreak in China.

Changes in cardiovascular mortality in Chile during the COVID-19 pandemic

Short- and medium-term impacts of strict anti-contagion policies on non-COVID-19 mortality in China

Millions of Excess Cases and Thousands of Excess Deaths of Malaria Occurred Globally in 2020 During the COVID-19 Pandemic.

Estimating Global and Country-Specific Excess Mortality During the COVID-19 Pandemic